文献速递炎症性肠病消化内镜消化道肿瘤与早癌

染料染色内镜在炎症性肠病患者异型增生检测中优于高清白光内镜:随机对照试验的更新Meta分析

Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Gastroenterol · 2023-12-01

该更新Meta分析纳入6项随机对照试验共978例炎症性肠病监测结肠镜检查患者,比较染料染色内镜(DCE)与高清白光内镜(HD-WLE)的异型增生检出。DCE组检出异型增生的患者比例显著高于HD-WLE组(18.8% vs 9.4%,OR 1.94,95%CI 1.21-3.11,P=0.006,高证据质量)。作者认为在具备专业技术时,高危炎症性肠病患者的监测结肠镜检查应考虑DCE。

要点

  • DCE检出异型增生的患者比例显著高于HD-WLE(18.8% vs 9.4%)。
  • 高级别异型增生检出率DCE组数值上更高但差异无统计学意义(2.8% vs 1.1%)。
  • 作者认为具备专业技术时高危炎症性肠病监测结肠镜可考虑DCE。

核心结论

  • 该更新Meta分析支持DCE在炎症性肠病总体异型增生检测中优于HD-WLE,即使使用高清内镜。
  • 作者认为当具备专业技术时,高危炎症性肠病患者的监测结肠镜检查应考虑DCE,同时承认近期研究显示虚拟染色内镜具有等效性。

研究设计与样本

  • 研究为随机对照试验的更新Meta分析,纳入6项随机对照试验共978例患者(DCE组479例 vs HD-WLE组499例)。
  • 检索比较炎症性肠病患者中HD-WLE与DCE的随机对照试验,主要结局为比较DCE与HD-WLE检出至少1个异型增生病变的患者比例。
  • 采用随机效应模型合并比值比(OR)和95%置信区间(CI),I²>60%表示存在实质性异质性,并使用推荐分级的评估、制定与评价(GRADE)方法评估证据质量(CoE)。

主要发现

  • DCE检出异型增生的患者比例显著高于HD-WLE(18.8% vs 9.4%),OR 1.94(95%CI 1.21-3.11,I²=28%,P=0.006,高证据质量)。
  • 排除2项以摘要形式发表的随机对照试验后,结果仍显著。
  • 排除一项由单一经验丰富操作者实施的非劣效性随机对照试验后,异质性消除,OR 2.46(95%CI 1.56-3.90,I²=0%)。
  • 高级别异型增生检出率DCE组数值上高于HD-WLE组(2.8% vs 1.1%),但差异无统计学意义,OR 2.21(95%CI 0.64-7.62,I²=0%,低证据质量)。

临床怎么用

  • 作者认为当具备专业技术时,高危炎症性肠病患者的监测结肠镜检查应考虑DCE。
  • 作者同时承认近期研究显示虚拟染色内镜具有等效性。
  • 作者指出需要由多名不同专业水平的内镜医师参与的多中心试验,以及显示癌症或癌症相关死亡减少的长期结局数据。

局限性

  • 作者指出需要由多名不同专业水平的内镜医师参与的多中心试验。
  • 作者指出需要显示癌症或癌症相关死亡减少的长期结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Whether dye spray chromoendoscopy (DCE) adds value in surveillance colonoscopy with high-definition (HD) scopes remains controversial. This updated meta-analysis compares dysplasia detection using DCE and high-definition white light endoscopy (HD-WLE) in patients with inflammatory bowel disease (IBD) undergoing surveillance colonoscopy. METHODS: A comprehensive search was performed for randomized controlled trials (RCT) comparing HD-WLE and DCE in patients with IBD. The primary outcome was to compare the proportion of patients with at least 1 dysplastic lesion detected by DCE vs HD-WLE. Odds ratios (OR) and 95% confidence intervals (CI) were pooled using the random-effects model, with I2 > 60% indicating substantial heterogeneity. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to assess the certainty of evidence (CoE). RESULTS: Six RCT involving 978 patients were analyzed (DCE = 479 vs HD-WLE = 499 patients). DCE detected significantly more patients with dysplasia than HD-WLE (18.8% vs 9.4%), OR 1.94 (95% CI 1.21-3.11, I2 = 28%, P = 0.006, high CoE). This remained significant after excluding 2 RCT published as abstracts. A sensitivity analysis excluding a noninferiority RCT with a single experienced operator eliminated the results' heterogeneity, OR 2.46 (95% CI 1.56-3.90, I2 = 0%). Although high-grade dysplasia detection was numerically higher in the DCE group (2.8% vs 1.1%), the difference was statistically insignificant, OR 2.21 (95% CI 0.64-7.62, I2 = 0%, low CoE). DISCUSSION: Our updated meta-analysis supports DCE as a superior strategy in overall dysplasia detection in IBD, even with HD scopes. When expertise is available, DCE should be considered for surveillance colonoscopy in patients with high-risk IBD, with the acknowledgment that virtual chromoendoscopy shows equivalence in recent studies. Further multicenter trials with multiple endoscopists with varying expertise levels and longer-term outcome data showing a reduction in cancer or cancer-related death are needed.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Mohamed MFH, Marino D, Elfert K, et al. Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2023. PMID: 38038351. doi:10.14309/ajg.0000000000002595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。